Tainted Weight Loss Pills

| 15/01/2009

(CNS): Following an advisory issued by the United States Food and Drug Administration (FDA) last month, the Medical Officer of Health, Dr Kiran Kumar is alerting consumers not to purchase or consume over 25 different products marketed for weight loss because they contain undeclared, active pharmaceutical ingredients that may put consumers’ health at risk.

According to USA Today, the FDA is adding an additional 41 products to their previous alert about tainted diet pills, bringing the total to 69.

According to the FDA these tainted weight loss products pose a great risk to public health because they contain undeclared ingredients and, in some cases, contain either unapproved drugs or prescription drugs in amounts that greatly exceed their maximum recommended dosages.

The health risks posed by these products can be serious; for example, sibutramine, which was found in many of the products, can cause high blood pressure, seizures, tachycardia, palpitations, heart attack or stroke. This drug can also interact with other medications that patients may be taking and increase their risk of adverse drug events. The safety of sibutramine has also not been established in pregnant and lactating women, or in children younger than 16 years of age.

Dr Kumar advises consumers who have used any of these products to stop taking them and consult their healthcare professional immediately and encourages consumers to seek guidance from a healthcare professional before purchasing weight loss products.

The tainted weight loss products listed by the HSA are:

Fatloss Slimming
2 Day Diet     
3x Slimming Power
Japan Lingzhi  24 Hours Diet
5x Imelda Perfect Slimming
3 Day Diet
7 Day Herbal Slim
8 Factor Diet
7 Diet Day/Night Formula
999 Fitness Essence
Extrim Plus
Imelda Perfect Slim
Lida DaiDaihua
Miaozi Slim Capsules
Perfect Slim
Perfect Slim 5x
Phyto Shape
ProSlim Plus
Royal Slimming Formula
Slim 3 in 1
Slim Express 360
Zhen de Shou

Print Friendly, PDF & Email

Category: Headline News

About the Author ()

Comments are closed.